BioMarin Pharmaceutical Inc. (BMRN) Seen as Attractive Buy Ahead of Transcon-CNP PDUFA, Says Wells Fargo

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is adjacent connected our list.

TheFly reported connected February 18 that Wells Fargo & Company accrued its terms people for BMRN from $70 to $75 portion keeping an Overweight rating. The steadfast believes the upcoming Transcon-CNP PDUFA whitethorn people the last antagonistic catalyst for BMRN, and its sum-of-the-parts investigation indicates the banal is trading beneath its worth excluding Voxzogo. According to Wells Fargo, the existent stock terms presents a compelling accidental for purchase.

Furthermore, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported connected February 12 that it had completed the $850 cardinal offering of 5.500% elder unsecured notes that mature successful 2034 and were issued astatine par. In summation to different word indebtedness arrangements and disposable funds, the proceeds are chiefly intended to enactment the upcoming acquisition of Amicus Therapeutics and related transaction expenses.

The notes' proceeds were placed successful escrow pending the deal's completion, with the stipulation that they beryllium redeemed astatine afloat main positive accrued involvement successful the lawsuit that the acquisition is not completed by the deadline. In summation to having mean covenant restrictions and being guaranteed by definite subsidiaries, the notes were made disposable to eligible organization buyers and non-U.S. investors done a backstage offering.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is simply a biopharmaceutical institution processing and commercializing therapies for uncommon familial diseases, focusing connected enzyme replacement and gene-targeted treatments.

While we admit the imaginable of BMRN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Unstoppable Dividend Stocks to Buy According to Analysts and Dividend Champions, Contenders and Challengers list: 15 Highest Yielding Stocks.

Disclosure: None. Follow Insider Monkey connected Google News.